Ambrisentan
9 NDCs across 9 manufacturers|9 Generic,0 Brand
Ambrisentan is used to treat pulmonary hypertension, per the National Library of Medicine's MED-RT classification.
▸ More about this market▾ Less
The brand product was first FDA-approved on Jun 15, 2007, and the first generic was approved Mar 28, 2019. FDA's Orange Book lists 16 AB-rated (therapeutically equivalent) products for this ingredient. In 2024, Medicare Part D spent $268 million on Ambrisentan across 65,000 claims for 8,083 beneficiaries.
Ambrisentan is available as 9 NDCs from 9 manufacturers (9 generic, 0 brand), with NADAC prices from $8.21 to $8.21 per EA. Every pack size and labeler in this drug market is compared side-by-side below.
Total NDCs
9
9G / 0B
Manufacturers
9
competing in market
Price Spread
$8.21 – $8.21
per EA
7d Activity
avg -4.4% WoW · of 9 NDCs
Market Price Trend
Monthly average NADAC per unit, split by generic and brand.
Manufacturer Breakdown
9 manufacturers producing AMBRISENTAN
| Drug ↕ | Price | 7d Change ↕ |
|---|---|---|
AMBRISENTAN 10 MG TABLET | $8.2094 per EA | -4.39% |
AMBRISENTAN 10 MG TABLET | $8.2094 per EA | -4.39% |
AMBRISENTAN 10 MG TABLET | $8.2094 per EA | -4.39% |
AMBRISENTAN 10 MG TABLET | $8.2094 per EA | -4.39% |
AMBRISENTAN 10 MG TABLET | $8.2094 per EA | -4.39% |
AMBRISENTAN 10 MG TABLET | $8.2094 per EA | -4.39% |
AMBRISENTAN 10 MG TABLET | $8.2094 per EA | -4.39% |
AMBRISENTAN 10 MG TABLET | $8.2094 per EA | -4.39% |
AMBRISENTAN 10 MG TABLET | $8.2094 per EA | -4.39% |
Frequently Asked Questions
What is Ambrisentan used to treat?
Ambrisentan is used to treat pulmonary hypertension, per the National Library of Medicine's MED-RT classification.
When did Ambrisentan become available as a generic?
FDA approved the first generic Ambrisentan (ANDA) on Mar 28, 2019. The Orange Book currently lists 16 AB-rated products for this ingredient, meaning FDA considers them therapeutically equivalent to the brand.
How much does Medicare spend on Ambrisentan?
In 2024, Medicare Part D spent $268 million on Ambrisentan across 65,000 claims for 8,083 beneficiaries.
How many Ambrisentan products are on the market?
The Ambrisentan drug market contains 9 NDCs from 9 manufacturers — 9 generic and 0 brand products.
What is the price range for Ambrisentan?
NADAC reference prices for Ambrisentan range from $8.2094 to $8.2094 per EA.
Which manufacturers make Ambrisentan?
9 manufacturers list Ambrisentan in NADAC. Ranked by number of NDCs, the largest are Mylan Pharmaceuticals Inc. (1), Actavis Pharma, Inc. (1), Sigmapharm Laboratories LLC (1), Sun Pharmaceutical Industries Inc. (1), Aurobindo Pharma Limited (1).
How has the price of Ambrisentan changed recently?
Over the past 7 days, 0 Ambrisentan NDCs rose and 9 fell, with a market-wide average change of -4.4%.